Literature DB >> 114339

A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes.

J J Hopwood, V Muller, A Smithson, N Baggett.   

Abstract

Incubation of 4-methylumbelliferyl alpha-L-iduronide with whole cell homogenates prepared from cultured skin fibroblasts and amniotic cells, and peripheral blood leukocytes gave 4-methylumbelliferone which was easily measured fluorometrically. This reaction, presumably due to the action of alpha-L-iduronidase, has a maximum hydrolytic activity at pH 3.25. The apparent KM value of alpha-L-iduronidase in leukocyte whole cell homogenates for this substrate was 179 mumol/l compared to 353, 41 and 166 mumol/l for other alpha-L-iduronidase substrates phenyl alpha-L-iduronide, iduronosyl anhydrol[1-3H]mannitol 6-sulfate and iduronosyl anhydro[1-3H]mannitol respectively; the corresponding Vmax values were 617, 394, 158 and 10 pmol/min/mg protein respectively. Incubation of the 4-methylumbelliferyl alpha-L-iduronide with whole cell homogenates prepared from cultured skin fibroblasts and leukocytes from a Hurler patient gave 4-methylumbelliferone at a rate more than 20 times less than found for control normal preparations. 4-Methylumbelliferyl alpha-L-iduronide is a sensitive, convenient and superior substrate to phenyl alpha-L-iduronide for the assay of alpha-L-iduronidase activity, but is not a suitable replacement for the radiolabelled substrate iduronosyl anhydro[1-3H]mannitol 6-sulfate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114339     DOI: 10.1016/0009-8981(79)90121-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  36 in total

1.  Feasibility of using cryopreserved lymphoblastoid cells to diagnose some lysosomal storage diseases.

Authors:  A S de Mello; F Provin; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

2.  Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.

Authors:  Min-Ju Chan; Hsuan-Chieh Liao; Michael H Gelb; Chih-Kuang Chuang; Mei-Ying Liu; Hsiao-Jan Chen; Shu-Min Kao; Hsiang-Yu Lin; You-Hsin Huang; Arun Babu Kumar; Naveen Kumar Chennamaneni; Nagendar Pendem; Shuan-Pei Lin; Chuan-Chi Chiang
Journal:  J Pediatr       Date:  2018-11-06       Impact factor: 4.406

3.  Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment.

Authors:  Valeska Lizzi Lagranha; Barbara Zambiasi Martinelli; Guilherme Baldo; Giuseppe Ávila Testa; Talita Giacomet de Carvalho; Roberto Giugliani; Ursula Matte
Journal:  J Mater Sci Mater Med       Date:  2017-02-01       Impact factor: 3.896

4.  Standardization of α-L-iduronidase enzyme assay with Michaelis-Menten kinetics.

Authors:  Li Ou; Tyler L Herzog; Carrie M Wilmot; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2013-11-26       Impact factor: 4.797

5.  Biochemical diagnosis of mucopolysaccharidoses: experience of 297 diagnoses in a 15-year period (1977-1991).

Authors:  P Di Natale; T Annella; A Daniele; T De Luca; E Morabito; R Pallini; P Rosario; G Spagnuolo
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.

Authors:  S Fujibayashi; R Minami; Y Ishikawa; K Wagatsuma; T Nakao; S Tsugawa
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Long-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantation.

Authors:  Ching-Chia Wang; Wuh-Liang Hwu; Kai-Hsin Lin
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

8.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

9.  Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation.

Authors:  C Navarro; C Dominguez; M Costa; J J Ortega
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Use of 4-trifluoromethylumbelliferyl-alpha-L-iduronide as a new substrate for detection of alpha-L-iduronidase deficiency in human tissues and for rapid prenatal diagnosis of Hurler disease.

Authors:  I V Tsvetkova; E A Karpova; Y V Voznyi; T V Zolotukhina; V V Biryukov; A N Semyachkina
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.